These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 34717679)

  • 1. T-cell dysregulation is associated with disease severity in Parkinson's Disease.
    Bhatia D; Grozdanov V; Ruf WP; Kassubek J; Ludolph AC; Weishaupt JH; Danzer KM
    J Neuroinflammation; 2021 Oct; 18(1):250. PubMed ID: 34717679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T lymphocyte senescence is attenuated in Parkinson's disease.
    Kouli A; Jensen M; Papastavrou V; Scott KM; Kolenda C; Parker C; Solim IH; Camacho M; Martin-Ruiz C; Williams-Gray CH
    J Neuroinflammation; 2021 Oct; 18(1):228. PubMed ID: 34645462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroinflammation and protein pathology in Parkinson's disease dementia.
    Kouli A; Camacho M; Allinson K; Williams-Gray CH
    Acta Neuropathol Commun; 2020 Dec; 8(1):211. PubMed ID: 33272323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parkinson's disease patients have a complex phenotypic and functional Th1 bias: cross-sectional studies of CD4+ Th1/Th2/T17 and Treg in drug-naïve and drug-treated patients.
    Kustrimovic N; Comi C; Magistrelli L; Rasini E; Legnaro M; Bombelli R; Aleksic I; Blandini F; Minafra B; Riboldazzi G; Sturchio A; Mauri M; Bono G; Marino F; Cosentino M
    J Neuroinflammation; 2018 Jul; 15(1):205. PubMed ID: 30001736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of Peripheral Blood iNKT and γδT Cells in Patients With Parkinson's Disease: An Observational Study.
    Zhou C; Zhou X; He D; Li Z; Xie X; Ren Y
    Front Immunol; 2020; 11():1329. PubMed ID: 32670293
    [No Abstract]   [Full Text] [Related]  

  • 6. CD4+ regulatory and effector/memory T cell subsets profile motor dysfunction in Parkinson's disease.
    Saunders JA; Estes KA; Kosloski LM; Allen HE; Dempsey KM; Torres-Russotto DR; Meza JL; Santamaria PM; Bertoni JM; Murman DL; Ali HH; Standaert DG; Mosley RL; Gendelman HE
    J Neuroimmune Pharmacol; 2012 Dec; 7(4):927-38. PubMed ID: 23054369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T cell infiltration and upregulation of MHCII in microglia leads to accelerated neuronal loss in an α-synuclein rat model of Parkinson's disease.
    Subbarayan MS; Hudson C; Moss LD; Nash KR; Bickford PC
    J Neuroinflammation; 2020 Aug; 17(1):242. PubMed ID: 32799878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. gamma delta+ T cells are increased in patients with Parkinson's disease.
    Fiszer U; Mix E; Fredrikson S; Kostulas V; Olsson T; Link H
    J Neurol Sci; 1994 Jan; 121(1):39-45. PubMed ID: 8133310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma VCAM1 levels correlate with disease severity in Parkinson's disease.
    Perner C; Perner F; Gaur N; Zimmermann S; Witte OW; Heidel FH; Grosskreutz J; Prell T
    J Neuroinflammation; 2019 May; 16(1):94. PubMed ID: 31068198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations of p11 in brain tissue and peripheral blood leukocytes in Parkinson's disease.
    Green H; Zhang X; Tiklova K; Volakakis N; Brodin L; Berg L; Greengard P; Perlmann T; Svenningsson P
    Proc Natl Acad Sci U S A; 2017 Mar; 114(10):2735-2740. PubMed ID: 28137881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypocretin (orexin) cell loss in Parkinson's disease.
    Thannickal TC; Lai YY; Siegel JM
    Brain; 2007 Jun; 130(Pt 6):1586-95. PubMed ID: 17491094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homologous HSV1 and alpha-synuclein peptides stimulate a T cell response in Parkinson's disease.
    Caggiu E; Paulus K; Galleri G; Arru G; Manetti R; Sechi GP; Sechi LA
    J Neuroimmunol; 2017 Sep; 310():26-31. PubMed ID: 28778441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unaltered T cell responses to common antigens in individuals with Parkinson's disease.
    Williams GP; Muskat K; Frazier A; Xu Y; Mateus J; Grifoni A; da Silva Antunes R; Weiskopf D; Amara AW; Standaert DG; Goldman JG; Litvan I; Alcalay RN; Sulzer D; Lindestam Arlehamn CS; Sette A
    J Neurol Sci; 2023 Jan; 444():120510. PubMed ID: 36495691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Astrocytes have the capacity to act as antigen-presenting cells in the Parkinson's disease brain.
    Rostami J; Fotaki G; Sirois J; Mzezewa R; Bergström J; Essand M; Healy L; Erlandsson A
    J Neuroinflammation; 2020 Apr; 17(1):119. PubMed ID: 32299492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in Blood Monocyte Functions in Parkinson's Disease.
    Nissen SK; Shrivastava K; Schulte C; Otzen DE; Goldeck D; Berg D; Møller HJ; Maetzler W; Romero-Ramos M
    Mov Disord; 2019 Nov; 34(11):1711-1721. PubMed ID: 31449711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of peripheral lymphocyte subpopulations and the clinical correlation with Parkinson's disease.
    Niwa F; Kuriyama N; Nakagawa M; Imanishi J
    Geriatr Gerontol Int; 2012 Jan; 12(1):102-7. PubMed ID: 21929737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T1rho and T2rho MRI in the evaluation of Parkinson's disease.
    Nestrasil I; Michaeli S; Liimatainen T; Rydeen CE; Kotz CM; Nixon JP; Hanson T; Tuite PJ
    J Neurol; 2010 Jun; 257(6):964-8. PubMed ID: 20058018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between serum RANTES levels and the severity of Parkinson's disease.
    Tang P; Chong L; Li X; Liu Y; Liu P; Hou C; Li R
    Oxid Med Cell Longev; 2014; 2014():208408. PubMed ID: 25587378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Constipation Increases Disability and Decreases Dopamine Levels in the Nigrostriatal System through Gastric Inflammatory Factors in Parkinson's Disease.
    Zhou Y; Su Y; Xu W; Wang W; Yao S
    Curr Neurovasc Res; 2019; 16(3):241-249. PubMed ID: 31258082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex Differences in Clinical Features of Early, Treated Parkinson's Disease.
    Augustine EF; Pérez A; Dhall R; Umeh CC; Videnovic A; Cambi F; Wills AM; Elm JJ; Zweig RM; Shulman LM; Nance MA; Bainbridge J; Suchowersky O
    PLoS One; 2015; 10(7):e0133002. PubMed ID: 26171861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.